A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
Background. Cervical cancer (CC) is a major malignancy affecting women worldwide, with limited treatment options for patients with advanced disease. The aim of this study was to identify novel prognostic biomarkers for CC. Methods. RNA-Seq data from four Gene Expression Omnibus datasets (GSE5787, GS...
Saved in:
| Main Authors: | Jun Wang, Hua Zheng, Yatian Han, Geng Wang, Yanbin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2020/4535820 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative Analysis of Novel Ferroptosis‐Related Genes Signatures as Prognostic Biomarkers in Ovarian Cancer
by: Leilei Cao, et al.
Published: (2025-08-01) -
Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma
by: Tong Zhao, et al.
Published: (2025-07-01) -
Eight Aging-Related Genes Prognostic Signature for Cervical Cancer
by: Meilin Yin, et al.
Published: (2023-01-01) -
Prognostic Value of Ferroptosis-Immunity-Related Signature Genes in Cervical Cancer Radiotherapy Resistance and Risk Modeling
by: Zhang X, et al.
Published: (2025-03-01) -
Development and Validation of an Anoikis-Related Gene Signature for Prognostic Prediction in Cervical Cancer
by: Meng S, et al.
Published: (2025-06-01)